Bone Biologics Corp — Director's Dealing 2022

Feb 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2021-10-26

Reporting Person: Angle Siddhesh Rajendra (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-26	Non-Employee Stock Option	$5.25	A	2949	Acquired	2031-10-26	Common Stock (2949)	Direct
2022-01-01	Non-Employee Stock Option	$3.52	A	8722	Acquired	2032-01-01	Common Stock (8722)	Direct

Footnotes

F1: Quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant.